Medpace Holdings (MEDP) Other Operating Expenses (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Other Operating Expenses came in at $505.8 million in Q2 2026, up 19.43% on a YoY basis from $423.5 million in Q2 2025, and down 0.9% quarter-over-quarter from $510.4 million in Q1 2026.
Analysis
Medpace Holdings (MEDP) Other Operating Expenses (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Other Operating Expenses for 12 consecutive years, with $505.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Operating Expenses rose 19.43% year-over-year to $505.8 million; the trailing twelve-month figure through Jun 2026 stood at $2.0 billion (up 29.83% YoY), and the FY2025 full-year result was $1.8 billion, up 21.75% from the prior year.
- Other Operating Expenses retreated to $505.8 million in Q2 2026 per MEDP's latest filing, from $510.4 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $510.4 million in Q1 2026 and bottomed at $233.1 million in Q1 2022.
- Historically, Other Operating Expenses has averaged $368.6 million across 5 years, with a median of $361.0 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Other Operating Expenses dropped 0.97% in 2024, then soared 40.35% in 2025.
- Over 5 years, Other Operating Expenses stood at $279.2 million in 2022, then increased by 29.71% to $362.1 million in 2023, then fell by 0.97% to $358.6 million in 2024, then jumped by 40.35% to $503.3 million in 2025, then climbed by 0.5% to $505.8 million in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $505.8 million, $510.4 million, and $503.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 505.85 Mn |
| Mar 31, 2026 | 510.43 Mn |
| Dec 31, 2025 | 503.35 Mn |
| Sep 30, 2025 | 463.20 Mn |
| Jun 30, 2025 | 423.54 Mn |
| Mar 31, 2025 | 380.46 Mn |
| Dec 31, 2024 | 358.63 Mn |
| Sep 30, 2024 | 364.67 Mn |
| Jun 30, 2024 | 374.63 Mn |
| Mar 31, 2024 | 356.26 Mn |
| Dec 31, 2023 | 362.15 Mn |
| Sep 30, 2023 | 359.86 Mn |
| Jun 30, 2023 | 337.10 Mn |
| Mar 31, 2023 | 304.44 Mn |
| Dec 31, 2022 | 279.19 Mn |
| Sep 30, 2022 | 265.55 Mn |
| Jun 30, 2022 | 253.05 Mn |
| Mar 31, 2022 | 233.11 Mn |
| Dec 31, 2021 | 221.85 Mn |
| Sep 30, 2021 | 209.75 Mn |